GC
ABCL icon

Gruss & Co’s AbCellera Biologics ABCL Stock Holding History

Gruss & Co’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$646K – 18
2023
Q2 		$646K Sell
100,000
-67,500
-40% -$461K 3.92% 12
2023
Q1 		$1.26M Sell
167,500
-87,900
-34% -$798K 7.99% 5
2022
Q4 		$2.59M Sell
255,400
-53,170
-17% -$614K 15.98% 1
2022
Q3 		$3.05M Sell
308,570
-55,208
-15% -$606K 26.27% 1
2022
Q2 		$3.87M Buy
363,778
+77,778
+27% +$659K 26.99% 1
2022
Q1 		$2.79M Sell
286,000
-140,966
-33% -$1.33M 12.38% 1
2021
Q4 		$6.11M Sell
426,966
-3,441
-0.8% -$52.2K 16.39% 1
2021
Q3 		$8.63M Buy
+430,407
New +$7.61M 24.12% 1

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return